Drug Trial Radar · NCT02940886
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
Last checked: Nov 20, 2026Latest source record: Oct 6, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,512
Actual
Start
Nov 8, 2016
Primary completion
Mar 28, 2018
Study completion Mar 28, 2018
Sponsor
- Lead sponsor
- Pharmacosmos A/SIndustry
- Sponsor type
- Industry
- First posted
- Oct 21, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate safety and efficacy of iron isomaltoside/ferric derisomaltose (Monofer®/Monoferric®) compared with iron sucrose (Venofer®), in subjects diagnosed with IDA.
Conditions
- Iron Deficiency Anaemia
- Iron Deficiency Anemia
Interventions
Iron isomaltoside/ferric derisomaltoseDrug
Iron isomaltoside/ferric derisomaltose (Monofer®/Monoferric®; 100 mg/mL) was the test product in this trial. The dose of iron isomaltoside/ferric derisomaltose for the individual subject was set to 1000 mg. The dose was diluted in 100 mL 0.9 % sodium chloride (100 mL bags) and administered as a single IV infusion over approximately 20 minutes.
Iron sucroseDrug
Iron sucrose (Venofer®; 20 mg elemental iron/mL) was the comparator in this trial. Iron sucrose was administered as 200 mg undiluted IV injections over approximately 2-5 minutes and repeated according to standard practice or physician choice up to a maximum of five times within the first two weeks starting at baseline. A cumulative dose of 1000 mg was recommended.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Hemoglobin (Hb) From Baseline to Week 8Time frame: Baseline to week 8
- Incidence of Protocol-defined Serious or Severe Hypersensitivity ReactionsTime frame: Baseline to week 8
Locations
114 sites in 1 country. Site status is shown where the registry gives one.
Pharmacosmos Investigational Site
Birmingham, Alabama
Pharmacosmos Investigational Site
Dothan, Alabama
Pharmacosmos Investigational Site
Guntersville, Alabama
Pharmacosmos Investigational Site
Phoenix, Arizona
Pharmacosmos Investigational Site
Little Rock, Arkansas
Pharmacosmos Investigational Site
Little Rock, Arkansas
Pharmacosmos Investigational Site
Foothill Ranch, California
Pharmacosmos Investigational Site 1
La Mesa, California
Pharmacosmos Investigational Site 2
La Mesa, California
Pharmacosmos Investigational Site
Long Beach, California
Pharmacosmos Investigational Site
National City, California
Pharmacosmos Investigational Site 1
Northridge, California
Pharmacosmos Investigational Site 2
Northridge, California
Pharmacosmos Investigational Site
Oceanside, California
Pharmacosmos Investigational Site
Quartz Hill, California
Pharmacosmos Investigational Site
Rialto, California
Pharmacosmos Investigational Site
Riverside, California
Pharmacosmos Investigational Site
San Diego, California
Pharmacosmos Investigational Site
San Diego, California
Pharmacosmos Investigational Site
San Marcos, California
Pharmacosmos Investigational Site
Whittier, California
Pharmacosmos Investigational Site
Plainville, Connecticut
Pharmacosmos Investigational Site
Aventura, Florida
Pharmacosmos Investigational Site
Boynton Beach, Florida
Pharmacosmos Investigational Site 1
Doral, Florida
Pharmacosmos Investigational Site 2
Doral, Florida
Pharmacosmos Investigational Site
Doral, Florida
Pharmacosmos Investigational Site
Fort Lauderdale, Florida
Pharmacosmos Investigational Site
Hialeah, Florida
Pharmacosmos Investigational Site
Hialeah, Florida
Pharmacosmos Investigational Site
Hialeah, Florida
Pharmacosmos Investigational Site
Hollywood, Florida
Pharmacosmos Investigational Site
Jacksonville, Florida
Pharmacosmos Investigational Site
Kissimmee, Florida
Pharmacosmos Investigational Site
Lake City, Florida
Pharmacosmos Investigational Site
Lake Worth, Florida
Pharmacosmos Investigational Site
Lake Worth, Florida
Pharmacosmos Investigational Site
Miami, Florida
Pharmacosmos Investigational Site
Miami, Florida
Pharmacosmos Investigational Site
Miami, Florida
Showing 40 of 114 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.